Literature DB >> 33954796

Internal Migration and Leprosy in Shanghai from 2000 to 2019: an Epidemiological Study of New Cases.

Jianyu Zhu1, Chao Shi, Degang Yang, Yeqiang Liu, Jia Chen, Meiping Ye, Chunjie Liao, Zhichun Jing, Pingyu Zhou.   

Abstract

Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Massive internal migration from rural to urban areas poses new challenges for leprosy control in Shanghai, China. This retrospective epidemiological study examined new cases of leprosy diagnosed in Shanghai from 2000 to 2019, with emphasis on internal migration cases. There were 145 cases of leprosy in the study period; the majority of cases (89.0%) were internal migrants. Migrant cases had a mean of 25.4 months lag time from onset of symptoms to diagnosis, which was significantly longer than that of resident cases (mean 10.8 months, p < 0.001). Greater lag time from the first visit to diagnosis was observed in migrant cases (mean 23.2 months) compared with resident cases (mean 9.4 months, p < 0.001). A large majority of cases (91.0%) had been misdiagnosed. Internal migrant cases were responsible for most incidences of leprosy in Shanghai. They often did not receive timely diagnosis and treatment, which may have an adverse impact on the prevention of epidemic leprosy.

Entities:  

Keywords:  epidemiology; internal migration; public health; leprosy

Mesh:

Year:  2021        PMID: 33954796      PMCID: PMC9367033          DOI: 10.2340/00015555-3821

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  25 in total

1.  Eradicating leprosy in Saudi Arabia: outcome of a ten-year surveillance (2003–2012).

Authors:  Abdullah Assiri; Saber Yezli; Tamara Tayeb; Malak Almasri; Afolabi E Bamgboye; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2014 Nov-Dec       Impact factor: 6.211

2.  Global leprosy update, 2013; reducing disease burden.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-09-05

3.  Global leprosy update, 2015: time for action, accountability and inclusion.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-09-02

Review 4.  Epidemiological aspects of leprosy.

Authors:  Gargi Sarode; Sachin Sarode; Rahul Anand; Shankargouda Patil; Mohammed Jafer; Hosam Baeshen; Kamran Habib Awan
Journal:  Dis Mon       Date:  2019-12-02       Impact factor: 3.800

5.  Factors affecting patient delay of diagnosis and completion of Direct Observation Therapy, Short-course (DOTS) among the migrant population in Shandong, China.

Authors:  Ruoyan Gai Tobe; Lingzhong Xu; Chengchao Zhou; Qing Yuan; Hong Geng; Xingzhou Wang
Journal:  Biosci Trends       Date:  2013-06       Impact factor: 2.400

6.  On the origin of leprosy.

Authors:  Marc Monot; Nadine Honoré; Thierry Garnier; Romulo Araoz; Jean-Yves Coppée; Céline Lacroix; Samba Sow; John S Spencer; Richard W Truman; Diana L Williams; Robert Gelber; Marcos Virmond; Béatrice Flageul; Sang-Nae Cho; Baohong Ji; Alberto Paniz-Mondolfi; Jacinto Convit; Saroj Young; Paul E Fine; Voahangy Rasolofo; Patrick J Brennan; Stewart T Cole
Journal:  Science       Date:  2005-05-13       Impact factor: 47.728

Review 7.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

8.  [Epidemiological survey of leprosy conducted in metropolitan France between 2009 and 2010].

Authors:  S Bret; B Flageul; P-Y Girault; E Lightburne; J-J Morand
Journal:  Ann Dermatol Venereol       Date:  2013-03-22       Impact factor: 0.777

9.  Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong Province, China.

Authors:  Mingzhou Xiong; Ming Li; Daocheng Zheng; Xiaohua Wang; Ting Su; Yongfeng Chen; Bin Yang
Journal:  BMC Infect Dis       Date:  2017-12-11       Impact factor: 3.090

Review 10.  On the age of leprosy.

Authors:  Xiang Y Han; Francisco J Silva
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.